If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 25 Mar: Advancing outdoor mosquito biting tools: IVCC and Molecular Attraction launch new collaboration
• 12 Feb: IVCC welcomes Ifakara Health Institute visit to strengthen technical collaboration
• 2 Mar: Doris Macharia Elected President of TB Alliance’s Global TB Stakeholders, Joins Board of Directors
• Mar 23: Antabio and GARDP join forces to identify potential next-generation antibiotics
• 4 Mar: Non-traditional partners drive malaria vaccine uptake in the DRC
• 16 Mar: Strengthening capacity for drug discovery and development in sub-Saharan Africa
• 18 Mar: MMV aims to tackle some tough malaria challenges with three new AI projects in drug discovery and development
• 26 Mar: Collaborative science, new treatments and stronger research leadership: PAMAfrica’s legacy
• 31 Mar: Free AI drug discovery platform aims to level the playing field for global health research
• 4 Mar: Pandemic preparedness: Novo Nordisk Foundation renews its support to DNDi and THSTI to continue the development of broad-spectrum antivirals
• 23 Mar: DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement
• 10 Feb: Statement on Brazil’s draft National Action Plan for Antimicrobial Resistance
• 10 Feb: DNDi and Dubai Health launch Middle East partnership to advance research and training in neglected diseases
• 20 Feb: DNDi welcomes GHIT support for lead identification of a novel chemical series in the Eisai-led Chagas disease project
• 27 Feb: Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
• 3 Mar: IVI and H3D Foundation partner to advance drug and vaccine research and scientific capacity in Africa
• 26 Mar: IVI and Brazil sign letter of intent supporting the establishment of the BRIGHT Fund, advancing a Global South-led model for health innovation
• 10 Feb: EVI supports first-in-human clinical trial of novel Nipah virus vaccine
MDGH
• 30 Jan: MDGH starts its Phase 2 clinical trial of dovramilast in people with leprosy type 2 reaction
PDP Funder News/Announcements
• 5 Mar: South Africa launches bid to enable local production of long-acting HIV prevention drug, lenacapavir. Unitaid
• 13 Mar: New Stakeholders’ Group members to advise on the programme. EDCTP
• 13 Mar: Madagascar joins the EDCTP Association. EDCTP3
• 20 Mar: The TB response must work for everyone – including those it has historically overlooked. Unitaid
• 26 Mar: Learning from history to find success in a new TB vaccine. Gates Foundation
• 30 Mar: GHIT Fund and Thailand Science Research and Innovation to strengthen partnership through co-funding initiative. GHIT
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 10 Mar: Tools to fight AMR exist, but industry-wide action is needed to tilt the battle against superbugs. Access to Medicines Foundation
• 13 Mar: From Commitments to Action: Practical Pathways for Health Financing in Africa. Global Health Strategies
Related Press Releases/ Announcements/Articles
• 1 Feb: It is time for a World Health Assembly resolution on global health architecture reform. LSE Global Health
• 2 Feb: Global health systems ‘at risk’ as funding cuts bite, warns WHO. UN News
• 2 Feb: Serious side effects dim hopes for the first chikungunya vaccine. Science
• 2 Feb: Six years after COVID-19’s global alarm: Is the world better prepared for the next pandemic?. WHO
• 2 Feb: An African-built solution to a worldwide cholera vaccine shortage. Wellcome
• 2 Feb: Preparing today for tomorrow’s Lassa fever vaccines. CEPI
• 2 Mar: Women’s health research: A history of progress, a future of opportunity. GHTC
• 2 Mar: A titan of vaccine development sees his field’s achievements slip away. STAT
• 2 Mar: Malaria vaccination reduces hospitalisations, deaths of children in northwestern Nigeria. Gavi
• 3 Mar: Single-dose treatment approved for sleeping sickness. Nature
• 3 Mar: Insights on global health reform discussions, trends and perspectives: March 2026. Partnership for International Politics and Diplomacy for Health
• 3 Mar: Not so good news for adults on malaria vaccine. The Standard
• 3 Mar: Tracking the "America First" Bilateral Health Agreements. Think Global Health
• 3 Mar: EIB says it’s ‘carrying the flag of development’. Devex
• 3 Mar: Shaping markets for health: How the Global Fund plans to secure affordable health products for the future. AIDSPAN
• 3 Mar: Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update. Nature
• 4 Mar: First global "early warning system" for dengue launches. LSHTM
• 4 Mar: State Department eyes tuberculosis breakthroughs. Devex
• 4 Mar: mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts. Human Vaccines & Immunotherapeutics
• 4 Mar: Study warns of underrecognized Lassa fever threat with global implications. MedicalXpress
• 4 Feb: Quick test can curb antimicrobial resistance, identifying bacteria and antibiotic susceptibility in under 40 minutes. Phys.org
• 4 Feb: Mutation behind insecticide resistance in Africa’s malaria mosquito identified. Genetic Engineering & Biotechnology News
• 4 Feb: Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy. Health Policy Watch
• 4 Feb: Leishmaniasis: a story of two continents. The Lancet
• 4 Feb: CEPI and Korea discuss future of AI-driven international health cooperation. CEPI
• 4 Feb: South Africa launches trial of locally developed HIV vaccine. APA News
• 4 Feb: What partnerships are needed to ramp up the development of low-cost antimicrobial drugs?. Institute of Development Studies
• 4 Feb: Q&A: How Can Humanitarians Navigate the New Expanded Global Gag Rule?. Health Policy Watch
• 5 Mar: Gilead and South Africa are negotiating a license for local production of new HIV drug. STAT
• 5 Mar: Language and geographical bias limits global health research. BMJ
• 5 Mar: South Africa seeks local production of Gilead's HIV prevention drug. Reuters
• 5 Mar: One Billion Tests: Turning India’s Diagnostic Boom into Public Health Intelligence. IHP
• 5 Mar: GARDP to explore animal antibiotic as a potential superbug treatment. CIDRAP
• 5 Mar: Catalysing vaccines research, development and manufacturing in Nigeria: a qualitative exploration of industry stakeholders’ knowledge, perceptions and experience. Health Research & Policy Systems
• 5 Feb: Where is HIV prevention drug lenacapavir in ‘America First’ health deals?. Devex
• 5 Feb: Celebrating the women shaping the future of global health technologies. GHTC
• 6 Mar: Research capacity and decolonisation in Sub-Saharan Africa: a bibliometric analysis. BMJ
• 6 Mar: Uganda Extends Successful Malaria Intervention to Older Children. Health Policy Watch
• 6 Mar: Non-traditional partners drive malaria vaccine uptake in the DRC. Gavi
• 6 Mar: Can philanthropy fill the aid gap? 5 reality checks. Devex
• 6 Mar: New Report: The Case for Renewed Investment by the U.S. Department of Defense in Malaria Research and Development and Prevention. Malaria No More
• 8 Mar: WHO assistant director general Jeremy Farrar: 'In the age of disinformation, WHO must remain a normative power'. Geneva Solutions
• 9 Mar: Africa CDC and ECDC strengthen joint commitment to Global Health Security. Africa CDC
• 9 Mar: Scientists Get a Glimpse of How New Pandemics Are Made. The New York Times
• 9 Mar: Lassa fever is going undiagnosed in West Africa, risking global spread. Gavi
• 9 Mar: Mosquito-borne viruses, vaccine-borne hope. Nature
• 9 Mar: Time for an International Development Research Projects Association. CGD
• 10 Mar: Leaders’ call to correct bias in women’s health research and funding. Gavi
• 10 Mar: Will antimicrobial resistance outpace research?. Devex
• 10 Mar: Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn. The Guardian
• 10 Mar: Sabin Vaccine Institute Completes Enrollment in All Phase 2 Clinical Trials for cAd3-Marburg Vaccine and cAd3-Sudan Ebolavirus Vaccine. Sabin
• 10 Mar: Equatorial Guinea’s high-tech push to end malaria by 2030. The Independent Ghana
• 10 Mar: A new era of country ownership: introducing Gavi’s first-ever vaccine budgets. Gavi
• 10 Mar: New funding opportunity to accelerate infectious disease trials. NIHR
• 10 Mar: The Elders urge progress on Pathogen Access and Benefit Sharing Annex to secure a fair pandemic deal. The Elders
• 10 Mar: New IGWG Text: Strong Obligations To Share Pathogen Information, Lists Technology Transfer & Licensing As "Optional" Benefits. Geneva Health Files
• 11 Mar: Global Health Infrastructure is Changing. Why Getting it Right Matters. Health Policy Watch
• 11 Mar: Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge. Health Policy Watch
• 11 Mar: Our global health architecture needs urgent reform: the Pandemic Agreement could be the catalyst. Gavi
• 11 Mar: New malaria vaccine shows promise in preclinical trials. MedicalXpress
• 11 Mar: WHO releases new target product profiles for urgently needed antibiotics. WHO
• 11 Mar: UK health authorities join forces to champion foreign infectious disease trials. Clinical Trials Arena
• 11 Mar: Indonesia in the BRICS: What It Means for Global Health. Think Global Health
• 11 Mar: Experts fear ‘unethical’ vaccine trial in Africa is ‘prototype’ for US studies under RFK Jr. The Guardian
• 11 Mar: African countries are signing bilateral health deals with the US: virologist identifies the ‘red flags’. The Conversation
• 11 Mar: Dengue vaccine remains 80.5% effective against severe cases after five years. MedicalXpress
• 11 Mar: WHO targets new antibiotics to fight hospital ‘superbugs’. The Telegraph
• 11 Mar: Nipah virus: a regional threat south Asia keeps underestimating. The Lancet
• 11 Mar: Using mosquitoes to vaccinate bats could curb the spread of deadly diseases. Nature
• 11 Mar: Global research agenda on knowledge translation and evidence-informed policy-making: prioritizing research for better decision-making. WHO
• 12 Mar: The global health reform debate’s dangerous blindspot. Unitaid
• 12 Mar: Gates Foundation grant moves AltraTech molecular point-of-care HIV viral load test closer to market. 360Dx
• 12 Mar: Scientists turn mosquitoes into "flying vaccines. Gavi
• 12 Mar: Antimicrobial resistance: Pharma pipeline projects drop by over a third. The BMJ
• 12 Mar: Butantan dengue vaccine estimated to be 81% effective against severe disease for at least 5 years. CIDRAP
• 13 Mar: Amplifying African voices to lead science for better health. The Lancet
• 13 Mar: War in the Middle East will impact neglected disease R&D globally. Devex
• 13 Mar: Could 'fridge-free' vaccines transform global immunisation?. UK Health Security Agency
• 13 Mar: The benefits to Americans of US-supported international HIV research. Health Affairs
• 13 Mar: Vaccinating bats could be good for people. But how do you vaccinate a bat?. NPR
• 13 Feb: Opinion: Future pandemics are inevitable – only by investing in science can we be ready. The Telegraph
• 13 Mar: South Africa wants to manufacture the world’s newest HIV prevention injection — can it build the capacity in time?. Medicines for Africa
• 13 Mar: The Current Landscape and Future Prospects of Vaccine Manufacturing in Africa: Challenges, Innovations, and Opportunities: A Narrative Review. Wiley
• 13 Mar: Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate. Oxford University
• 14 Mar: Health in Africa: the WHO African region in the next decade. The Lancet
• 14 Mar: US global health deals falter over sovereignty concerns. The Lancet
• 14 Feb: Presidential Declaration on Advancing Local Manufacturing of Health Products in Africa. Africa CDC
• 15 Feb: UK Aid Cuts Now Deeper than the US After Congress Pushes Back. CGD
• 15 Feb: Wide gaps on pandemic treaty annex cast doubt on May deadline, says health expert Suerie Moon. Geneva Solutions
• 15 Feb: Mpox vaccines: an urgent equity imperative. Vaccine
• 16 Feb: The WHO process for supporting the reform of the global health architecture. IHP
• 16 Feb: The Lusaka Agenda Shows the Power of Community Voices. Think Global Health
• 16 Feb: Call for 24 Countries to Ratify African Medicines Agency Treaty ‘Without Delay’. Health Policy Watch
• 16 Mar: Scientists turn mosquitoes ‘into a vaccination tool’ to immunise bats against rabies. The Telegraph
• 16 Mar: U.S. Considers Withholding H.I.V. Aid Unless Zambia Expands Minerals Access. The New York Times
• 16 Feb: Vaccine makers curtail research and cut jobs. The New York Times
• 16 Mar: CAB-LA: The prevention jab that never had its moment, and what it leaves behind as LEN arrives. Bhekisisa
• 17 Mar: Twenty years of PAHPA: Modernization through reauthorization. GHTC
• 17 Feb: Investment in malaria venture yields 13x health benefits. Health Policy Watch
• 18 Mar: Wellcome Report: Aid Cuts Catalyse Global Health Reform and Regional Cooperation. Health Policy Watch
• 18 Mar: Global Health Leaders Warn Trust in Science Is Declining. Health Policy Watch
• 18 Mar: New vaccine to stop deadly meningitis epidemics confirmed to be safe. Gavi
• 18 Mar: Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap. The Lancet
• 18 Feb: Excruciating tropical disease can now be transmitted in most of Europe, study finds. The Guardian
• 18 Feb: The fight against hepatitis in Africa hangs in the balance after US cuts: Clinics closed, fewer tests and canceled research. El Pais
• 18 Feb: Global Fund Board Welcomes Final Eighth Replenishment Outcome of US$12.64 Billion, Backs Strategic Shifts to Advance Countries’ Path to Self-Reliance. The Global Fund
• 19 Mar: How much does climate change fuel dengue outbreaks?. Gavi
• 19 Mar: Study finds rising resistance to a last-resort antibiotic in Africa. CIDRAP
• 19 Mar: 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enough. Bhekisisa
• 20 Mar: Gilead could potentially end HIV. But will it be able to?. PharmaVoice
• 20 Mar: Evidence into action: How do we make a new TB treatment with staying power?. FHI 360
• 20 Mar: UK lays out the development priorities of a shrinking aid budget. Devex
• 21 Mar: Global tuberculosis response off track: urgent priorities to end the world's top infectious killer. The Lancet
• 22 Mar: Needed: Greater Accountability on Pathogen Data Sharing, To Minimize Biosecurity Risks & To Boost Preparedness. Geneva Health Files
• 22 Mar: This lab that's determined to discover new drugs isn't where you might expect. NPR
• 23 Mar: Closing the persistent gap in TB diagnosis. GHTC
• 23 Mar: Tense Start to Final Pandemic Agreement Talks as Africa Rejects New Draft Text. Health Policy Watch
• 23 Mar: Pandemic Talks: Europe is Blocking Health Equity – And It Knows It. Health Policy Watch
• 23 Mar: New WHO recommendations for tuberculosis diagnosis. The Lancet
• 23 Mar: Intelligenome, Cornell to develop low-cost point-of-care tuberculosis diagnostic. 360Dx
• 23 Mar: Diagnostic innovations to find the missing millions with tuberculosis. The Lancet
• 23 Mar: The case for ambition: Why countries must move boldly on Near Point-of-Care TB Diagnostics. PLOS
• 23 Mar: New tongue-swab TB test could help eradicate the disease, WHO says. Forbes
• 23 Mar: The aid system is ‘unfit for purpose’. So what comes next?. The Telegraph
• 23 Mar: Here's what we know about Trump's expanded Mexico City Policy. Devex
• 23 Mar: African CSOs call for equity as pathogen access talks hit final stretch. Devex
• 24 Mar: Global Vaccine Security Still Needs International Cooperation: Are Middle Powers the Key?. CGD
• 24 Mar: Undetected Tuberculosis Crisis Plagues Europe; WHO Rolls Out New Diagnostic Tools. Health Policy Watch
• 24 Mar: WHO recommends new diagnostic tools to help end TB. WHO
• 24 Mar: Strengthening Access Planning: The Launch of Lenacapavir in Zambia. AVAC
• 24 Mar: Bridging the Gap Between Science and Communities: Delivering Accessible Information and Leading Global Conversations. AVAC
• 24 Mar: The world’s deadliest infectious disease is on the rise in the US. Vox
• 24 Mar: Sustaining Tuberculosis Innovations to Counter Foreign Aid Cuts. Think Global Health
• 24 Mar: New therapies are transforming treatment for drug-resistant TB – so why aren’t people getting them?. The Telegraph
• 24 Mar: New vaccines could help us consign tuberculosis to history: here’s how we can do it. Gavi
• 25 Mar: Multilane Procurement Amid the America First Health Agenda. Think Global Health
• 26 Mar: Boron plays a key role in new sleeping sickness drug. Chemistry World
• 26 Mar: Have your say on transforming global health. WHO
• 26 Mar: US Withdrawal of Global Health Funding is ‘Public Health Emergency of International Concern’. Health Policy Watch
• 27 Mar: NIH restrictions on research partnerships with foreign institutions significantly impacted 1 in 4 U.S. scientists. STAT
• 27 Mar: Global Health Watch: Pandemic Treaty Tensions, Public Health Emergency, CDC Instability & Global Fund’s Role in Bilateral Health Deals. AVAC
• 27 Mar: Study reveals genetic evolution of major malaria vector species in South America. News Medical
• 27 Mar: AfDB, Gates propose boosting government liquidity for health products. Devex
• 27 Mar: Bavarian Nordic submits data to EMA to extend mpox and smallpox vaccine approval to children aged 2-11 years. Bavarian Nordic
• 28 Mar: Another global health crisis is gaining momentum. We need to be prepared. The Hill
• 28 Mar: New Funding Models Needed as Global Health Faces Growing Financial Strain. Health Policy Watch
• 28 Mar: Building momentum at the African Medicines Agency. The Lancet
• 28 Mar: WHO Member States agree to extend negotiations on key annex to the Pandemic Agreement. WHO
• 28 Mar: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization. STAT
• 30 Mar: Vaccine-induced mouse antibodies targeting Plasmodium falciparum PfVFT antigen inhibit blood stages through multiple mechanisms. Nature
• 30 Mar: A New Compact for Health Financing: From Principle to Practice. CGD
• 30 Mar: Pandemic deal hangs in the balance as countries deadlocked over vaccine details. Politico
• 30 Mar: Decentralizing testing capacity of mpox in Africa: a narrative review. The Lancet
• 31 Mar: New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery. Health Policy Watch
• 31 Mar: What Will It Take for Development Agencies to Stay Effective in a Changing Landscape?. CGD
Upcoming Meetings/ Webinars
--------------------------